 $2 billion to gain experimental therapies for inflammatory bowel disease and other chronic illnesses. Lilly will pay $57 a share for the Massachusetts-based company. And the next time you head to Target, you can leave that checkbook at home. USA Today reporting starting next Monday, the retailer will no longer accept personal checks from customers. Kimberly Adams, Bloomberg Radio.